{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:42:46Z","timestamp":1790116966529,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.healun.2021.09.014","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T13:20:29Z","timestamp":1633353629000},"page":"255-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Risk factors of invasive fungal infections in lung transplant recipients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9503-4830","authenticated-orcid":false,"given":"Pakpoom","family":"Phoompoung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle Perez Cortes","family":"Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2920-802X","authenticated-orcid":false,"given":"Shilpa","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Foroutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9943-2692","authenticated-orcid":false,"given":"Ani","family":"Orchanian-Cheff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9216-5229","authenticated-orcid":false,"given":"Shahid","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2021.09.014_bib0001","first-page":"399","article-title":"Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole","volume":"9","author":"Hayes","year":"2011","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.healun.2021.09.014_bib0002","doi-asserted-by":"crossref","first-page":"e13085","DOI":"10.1111\/tid.13085","article-title":"Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia","volume":"21","author":"Chang","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0003","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/TP.0000000000000743","article-title":"The effectiveness of culture-directed preemptive anti-aspergillus treatment in lung transplant recipients at one year after transplant","volume":"99","author":"Hosseini-Moghaddam","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.09.014_bib0004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.healun.2014.09.036","article-title":"Risk factors for invasive fungal disease in heart transplant recipients","volume":"34","author":"Rabin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.09.014_bib0005","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/01.tp.0000441088.01723.ee","article-title":"Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection","volume":"97","author":"Tissot","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.09.014_bib0006","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.healun.2018.02.006","article-title":"A strategy for prevention of fungal infections in lung transplantation: role of bronchoalveolar lavage fluid galactomannan and fungal culture","volume":"37","author":"Husain","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.09.014_bib0007","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0008","doi-asserted-by":"crossref","first-page":"e13250","DOI":"10.1111\/tid.13250","article-title":"Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: a population-based cohort study","volume":"22","author":"Hosseini-Moghaddam","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0009","doi-asserted-by":"crossref","first-page":"e13630","DOI":"10.1111\/ctr.13630","article-title":"Antifungal prophylaxis in lung transplant: a survey of United States' transplant centers","volume":"33","author":"Pennington","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2021.09.014_bib0010","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/TP.0000000000001050","article-title":"Antifungal prophylaxis in lung transplant recipients","volume":"100","author":"Patel","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.09.014_bib0011","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11908-013-0380-y","article-title":"Anti-aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis","volume":"15","author":"Bhaskaran","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.healun.2021.09.014_bib0012","doi-asserted-by":"crossref","first-page":"e13333","DOI":"10.1111\/tid.13333","article-title":"Antifungal prophylaxis in lung transplant recipients: a systematic review and meta-analysis","author":"Pennington","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0013","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s40267-019-00699-5","article-title":"Long-term use of systemic azole antifungals can result in hepatotoxicity and other serious adverse effects","volume":"36","author":"Writers","year":"2020","journal-title":"Drugs The Perspect"},{"key":"10.1016\/j.healun.2021.09.014_bib0014","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/ajt.14500","article-title":"Voriconazole and squamous cell carcinoma after lung transplantation: a multicenter study","volume":"18","author":"Hamandi","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.09.014_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12751","article-title":"Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4","volume":"19","author":"Groll","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0016","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/TP.0b013e31825992f0","article-title":"Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis","volume":"94","author":"Egli","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.09.014_bib0017","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/tri.12679","article-title":"10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation","volume":"29","author":"Peghin","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2021.09.014_bib0018","first-page":"719","article-title":"Developing optimal search strategies for detecting clinically sound causation studies in MEDLINE","author":"Wilczynski","year":"2003","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.healun.2021.09.014_bib0019","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/514599","article-title":"Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients","volume":"26","author":"Husni","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ctr.12516","article-title":"Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis","volume":"29","author":"Chong","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2021.09.014_bib0021","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/tid.12492","article-title":"Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients","volume":"18","author":"Peghin","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0022","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1469-0691.2005.01128.x","article-title":"Aspergillus infections in lung transplant recipients: risk factors and outcome","volume":"11","author":"Sole","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.healun.2021.09.014_bib0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/tid.12362","article-title":"Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience","volume":"17","author":"Vazquez","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0024","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jinf.2013.03.013","article-title":"Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis","volume":"67","author":"Singh","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.healun.2021.09.014_bib0025","doi-asserted-by":"crossref","first-page":"e12560","DOI":"10.1111\/tid.12650","article-title":"Invasive fungal infection after heart transplantation: a 7-year, single-center experience","volume":"19","author":"Echenique","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0026","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.TP.0000437434.42851.d4","article-title":"Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis","volume":"97","author":"Luong","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.09.014_bib0027","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.healun.2018.06.008","article-title":"Clinical risk factors for invasive aspergillosis in lung transplant recipients: results of an international cohort study","volume":"37","author":"Aguilar","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.09.014_bib0028","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1053-2498(01)00364-3","article-title":"Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors","volume":"20","author":"Monforte","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.09.014_bib0029","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.3760\/cma.j.issn.0366-6999.20130252","article-title":"Pneumonia relevant to lung transplantation and pathogen distribution","volume":"126","author":"He","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.healun.2021.09.014_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.idc.0000230548.96251.70","article-title":"Aspergillus infections after lung transplantation","volume":"14","author":"Day","year":"2006","journal-title":"Infect Dise Clin Pract"},{"key":"10.1016\/j.healun.2021.09.014_bib0031","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(97)80021-6","article-title":"The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland","volume":"103","author":"George","year":"1997","journal-title":"Am J Med."},{"key":"10.1016\/j.healun.2021.09.014_bib0032","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1002\/ajh.25438","article-title":"Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia\/lymphoma","volume":"94","author":"Sawayama","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.healun.2021.09.014_bib0033","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/tid.12328","article-title":"Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients","volume":"17","author":"Atalla","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0034","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cmi.2017.06.016","article-title":"Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation","volume":"24","author":"Lopez-Medrano","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.healun.2021.09.014_bib0035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/clinids\/22.6.920","article-title":"Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients","volume":"22","author":"Arend","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0036","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/ciy682","article-title":"A Multicenter case-control study of the effect of acute rejection and cytomegalovirus infection on pneumocystis pneumonia in solid organ transplant recipients","volume":"68","author":"Hosseini-Moghaddam","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0037","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/QCO.0000000000000502","article-title":"Invasive fungal disease and cytomegalovirus infection: is there an association?","volume":"31","author":"Yong","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.healun.2021.09.014_bib0038","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/mmy\/myw121","article-title":"Aspergillus-related pulmonary diseases in lung transplantation","volume":"55","author":"Pasupneti","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.healun.2021.09.014_bib0039","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.leu.2403674","article-title":"Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies","volume":"19","author":"Muhlemann","year":"2005","journal-title":"Leukemia"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821025249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821025249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:43:59Z","timestamp":1760949839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249821025249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1053249821025249"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.09.014","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors of invasive fungal infections in lung transplant recipients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}